Metagenomi, Inc.
MGX
$1.73
$0.074.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.04M | -23.40M | -18.77M | -10.74M | -25.15M |
| Total Depreciation and Amortization | 1.36M | 1.46M | 1.36M | 1.31M | 1.27M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.12M | 11.12M | 3.33M | 3.87M | 4.94M |
| Change in Net Operating Assets | -2.28M | -15.46M | -12.55M | -20.75M | -10.91M |
| Cash from Operations | -22.84M | -26.28M | -26.64M | -26.31M | -29.85M |
| Capital Expenditure | -288.00K | -334.00K | -1.20M | -665.00K | -915.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.02M | 28.88M | -7.73M | -12.37M | -93.82M |
| Cash from Investing | 24.73M | 28.55M | -8.93M | -13.04M | -94.73M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | -- | -- | 86.54M |
| Repurchase of Common Stock | -- | -- | -492.00K | -2.03M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -77.00K | -- | -- | -- | -- |
| Cash from Financing | -77.00K | 0.00 | -492.00K | -2.03M | 86.54M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.81M | 2.27M | -36.06M | -41.38M | -38.05M |